CompuGroup Medical SE & Co. KGaA (XETRA:COP) — Stock Price

€22.66 EUR
▲ 0.00% today

CompuGroup Medical SE & Co. KGaA (XETRA:COP) is currently trading at €22.66 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €22.66 and €22.66. This page tracks CompuGroup Medical SE & Co. KGaA's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CompuGroup Medical SE & Co. KGaA market capitalisation.

CompuGroup Medical SE & Co. KGaA (COP) Stock Price Chart — Daily History & Trading Volume

The chart below tracks CompuGroup Medical SE & Co. KGaA's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Daily price history is not currently available for CompuGroup Medical SE & Co. KGaA.

CompuGroup Medical SE & Co. KGaA Income Statement — Revenue, Profit & Earnings by Year

CompuGroup Medical SE & Co. KGaA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €1.15 Billion €1.19 Billion €1.13 Billion €1.03 Billion €837.26 Million
Cost of Revenue €188.84 Million €182.61 Million €171.58 Million €739.44 Million €124.31 Million
Gross Profit €965.14 Million €1.01 Billion €958.16 Million €285.89 Million €712.95 Million
Research & Development €252.16 Million €106.20 Million €123.60 Million €81.80 Million
SG&A €25.30 Million €28.47 Million €33.26 Million €34.01 Million €33.17 Million
Total Operating Expenses €859.40 Million €882.12 Million €850.70 Million €763.29 Million €587.59 Million
Operating Income €105.74 Million €122.93 Million €107.46 Million €108.69 Million €125.37 Million
EBITDA €206.90 Million €215.84 Million €231.36 Million €216.63 Million €192.49 Million
EBIT €95.25 Million €100.04 Million €119.03 Million €105.91 Million €116.88 Million
Interest Expense €33.36 Million €24.34 Million €12.12 Million €8.07 Million €7.58 Million
Income Before Tax €61.89 Million €72.67 Million €106.82 Million €97.87 Million €110.43 Million
Income Tax Expense €27.13 Million €25.80 Million €32.70 Million €28.84 Million €37.01 Million
Net Income €34.60 Million €45.92 Million €73.41 Million €68.97 Million €73.19 Million

CompuGroup Medical SE & Co. KGaA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes CompuGroup Medical SE & Co. KGaA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €1.97 Billion €1.90 Billion €1.94 Billion €1.79 Billion €1.57 Billion
Total Current Assets €394.60 Million €369.83 Million €420.81 Million €370.78 Million €308.11 Million
Cash & Equivalents
Short-term Investments €427.00K €82.00K €497.00K €340.00K €1.00 Million
Net Receivables €201.56 Million €211.09 Million €221.87 Million €240.56 Million €213.20 Million
Inventory €14.71 Million €18.88 Million €29.44 Million €20.64 Million €18.16 Million
Property, Plant & Equipment €160.89 Million €158.00 Million €136.29 Million
Goodwill €735.86 Million €684.10 Million €639.16 Million €588.41 Million €542.45 Million
Total Liabilities €1.32 Billion €1.23 Billion €1.27 Billion €1.18 Billion €926.84 Million
Total Current Liabilities €331.25 Million €346.83 Million €375.47 Million €398.35 Million €290.54 Million
Long-term Debt €794.46 Million €704.25 Million €699.42 Million €17.75 Billion €470.20 Million
Net Debt €772.81 Million €702.48 Million €696.00 Million €634.02 Million €479.93 Million
Total Stockholder Equity €647.91 Million €667.68 Million €672.42 Million €612.07 Million €638.67 Million
Retained Earnings €40.67 Billion €35.21 Billion

CompuGroup Medical SE & Co. KGaA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how CompuGroup Medical SE & Co. KGaA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €128.88 Million €179.53 Million €145.03 Million €165.27 Million €149.93 Million
Capital Expenditures €63.23 Million €75.41 Million €81.04 Million €77.50 Million €55.73 Million
Free Cash Flow €65.66 Million €104.11 Million €63.99 Million €87.78 Million €94.20 Million
Investing Cash Flow €-105.28 Million €-124.33 Million €-145.41 Million €-163.98 Million €-457.12 Million
Financing Cash Flow €18.81 Million €-80.69 Million €-16.36 Million €30.15 Million €338.07 Million
Dividends Paid €51.73 Million €26.12 Million €26.12 Million €26.37 Million €24.21 Million
Stock-Based Compensation €-7.04 Million €2.64 Million €5.72 Million €5.88 Million
Depreciation €111.65 Million €115.80 Million €112.32 Million €110.71 Million €75.71 Million
Change in Cash €42.87 Million €-26.06 Million €-16.83 Million €31.43 Million €29.56 Million

CompuGroup Medical SE & Co. KGaA Earnings History — EPS Actual vs. Analyst Estimates

Track CompuGroup Medical SE & Co. KGaA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 28, 2026
Nov 05, 2025
Jul 31, 2025
Apr 30, 2025 0.35 0.41 -14.63%
Mar 26, 2025 0.11 0.39 -71.79%
Nov 07, 2024 0.35 0.30 +16.67%
Jul 15, 2024 0.27 0.50 -46.14%
May 08, 2024 0.47 0.38 +23.68%